STAT3 targeting in dystrophic epidermolysis bullosa.

Mittapalli, V R; Kühl, T; Kuzet, S E; Gretzmeier, C; Kiritsi, D; Gaggioli, C; Bruckner-Tuderman, L; Nyström, A

Mittapalli, V R; Kühl, T; Kuzet, S E; Gretzmeier, C; Kiritsi, D; Gaggioli, C; Bruckner-Tuderman, L; Nyström, A.

Afiliação

Mittapalli VR; Department of Dermatology, Medical Faculty, Medical Center - University of Freiburg, Freiburg, Germany.
Kühl T; Department of Dermatology, Medical Faculty, Medical Center - University of Freiburg, Freiburg, Germany.
Kuzet SE; University Côte d'Azur, CNRS UMR7284, INSERM U1081, Institute for Research on Cancer and Aging, Nice (IRCAN), Nice, France.
Gretzmeier C; Department of Dermatology, Medical Faculty, Medical Center - University of Freiburg, Freiburg, Germany.
Kiritsi D; Department of Dermatology, Medical Faculty, Medical Center - University of Freiburg, Freiburg, Germany.
Gaggioli C; University Côte d'Azur, CNRS UMR7284, INSERM U1081, Institute for Research on Cancer and Aging, Nice (IRCAN), Nice, France.
Bruckner-Tuderman L; Department of Dermatology, Medical Faculty, Medical Center - University of Freiburg, Freiburg, Germany.
Nyström A; Department of Dermatology, Medical Faculty, Medical Center - University of Freiburg, Freiburg, Germany.

Br J Dermatol ; 182(5): 1279-1281, 2020 05.

Article em En | MEDLINE | ID: mdl-31675440

Assuntos

Epidermólise Bolhosa Distrófica; Epidermólise Bolhosa; Epidermólise Bolhosa Distrófica/genética; Humanos; Fator de Transcrição STAT3/genética; Pele

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epidermólise Bolhosa Distrófica / Epidermólise Bolhosa Limite: Humans Idioma: En Revista: Br J Dermatol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google